Robert E. T. Towner
Director/Board Member chez STAE GAS
Profil
Robert E.
T.
Towner was the founder of bioMD Ltd.
(founded in 2004) where he held the title of Executive Director from 2004 to 2012.
He is also the founder of Cornerstone Corporate Pty Ltd.
(founded in 2009) where he currently holds the title of Executive Director.
Mr. Towner's current job(s) include Chairman at Telethon Type 1 Diabetes Family Centre, Non-Executive Director at State Gas Ltd.
(since 2017), Non-Executive Director at Type 1 Diabetes TrialNet, and Director at Flametree Wines.
Mr. Towner's former job(s) include CEO, Managing Director & Executive Director at Triangle Energy (Global) Ltd.
(2014-2022), Independent Non-Executive Director at Botanix Pharmaceuticals Ltd.
(2014-2020), and Executive Director at Anteris Technologies Ltd.
(2004-2012).
Postes actifs de Robert E. T. Towner
| Sociétés | Poste | Début |
|---|---|---|
| STAE GAS | Director/Board Member | 10/02/2017 |
| Cornerstone Corporate Pty Ltd. | Founder | 01/01/2009 |
| Telethon Type 1 Diabetes Family Centre | Chairman | - |
Type 1 Diabetes TrialNet
 Type 1 Diabetes TrialNet Miscellaneous Commercial ServicesCommercial Services Type 1 Diabetes TrialNet is an international network of leading academic institutions, endocrinologists, physicians, scientists, and healthcare teams that conduct research on type 1 diabetes (T1D). The non-profit company is based in Seattle, WA. The company offers risk screening for relatives of people with T1D and innovative clinical studies to slow down and prevent disease progression. The company's goal is to create a future without T1D. | Director/Board Member | - |
| Flametree Wines | Director/Board Member | - |
Anciens postes connus de Robert E. T. Towner
| Sociétés | Poste | Fin |
|---|---|---|
| TRIANGLE ENERGY (GLOBAL) LIMITED | Chief Executive Officer | 08/02/2022 |
| BOTANIX PHARMACEUTICALS LIMITED | Chairman | 01/07/2016 |
bioMD Ltd.
 bioMD Ltd. Miscellaneous Commercial ServicesCommercial Services bioMD Ltd. engages in the development and commercialization of medical therapy products. It researches and develops ADAPT process, which is used in the production of biomaterials derived from animals tissues for use as bioimplants for human use. The company is headquartered in Perth, Australia. | Founder | 01/08/2012 |
| ANTERIS TECHNOLOGIES LTD | Director/Board Member | 04/04/2012 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
| TRIANGLE ENERGY (GLOBAL) LIMITED | Energy Minerals |
| ANTERIS TECHNOLOGIES LTD | Health Technology |
| STAE GAS | Energy Minerals |
| Entreprise privées | 5 |
|---|---|
bioMD Ltd.
bioMD Ltd. Miscellaneous Commercial ServicesCommercial Services bioMD Ltd. engages in the development and commercialization of medical therapy products. It researches and develops ADAPT process, which is used in the production of biomaterials derived from animals tissues for use as bioimplants for human use. The company is headquartered in Perth, Australia. | Commercial Services |
| Cornerstone Corporate Pty Ltd. | |
| Telethon Type 1 Diabetes Family Centre | |
Type 1 Diabetes TrialNet
Type 1 Diabetes TrialNet Miscellaneous Commercial ServicesCommercial Services Type 1 Diabetes TrialNet is an international network of leading academic institutions, endocrinologists, physicians, scientists, and healthcare teams that conduct research on type 1 diabetes (T1D). The non-profit company is based in Seattle, WA. The company offers risk screening for relatives of people with T1D and innovative clinical studies to slow down and prevent disease progression. The company's goal is to create a future without T1D. | Commercial Services |
| Flametree Wines |
